Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Nolta

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Ophthalmology Science|February 16, 2026
Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and FeasibilitySusanna S Park, Jennifer McCormack, Dagmar Salazar, et al.
Stem Cells (Dayton, Ohio)|September 9, 2006
In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation modelsTodd E Meyerrose, Daniel A De Ugarte, A Alex Hofling, et al.
Lancet (London, England)|February 28, 2026
Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm studyDiana L Farmer, Priyadarsini Kumar, Elizabeth Reynolds, et al.
Molecular Neurobiology|December 14, 2011
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseScott D Olson, Kari Pollock, Amal Kambal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectorsGerhard Bauer, Mo A Dao, Scott S Case, et al.
Blood|March 28, 2009
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activityBenjamin J Capoccia, Debra L Robson, Krysta D Levac, et al.
Nucleic Acids Research|March 3, 2005
Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivoElisheva Smith, Todd E Meyerrose, Thomas Kohler, et al.
Cell Transplantation|February 7, 2016
Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease FibroblastsKyle D Fink, Peter Deng, Josh Gutierrez, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Transfusion|November 2, 2018
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditionsFernando A Fierro, Nataly Magner, Julie Beegle, et al.
Ophthalmology Science|February 16, 2026
Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and FeasibilitySusanna S Park, Jennifer McCormack, Dagmar Salazar, et al.
Stem Cells (Dayton, Ohio)|September 9, 2006
In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation modelsTodd E Meyerrose, Daniel A De Ugarte, A Alex Hofling, et al.
Lancet (London, England)|February 28, 2026
Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm studyDiana L Farmer, Priyadarsini Kumar, Elizabeth Reynolds, et al.
Molecular Neurobiology|December 14, 2011
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's diseaseScott D Olson, Kari Pollock, Amal Kambal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectorsGerhard Bauer, Mo A Dao, Scott S Case, et al.
Blood|March 28, 2009
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activityBenjamin J Capoccia, Debra L Robson, Krysta D Levac, et al.
Nucleic Acids Research|March 3, 2005
Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivoElisheva Smith, Todd E Meyerrose, Thomas Kohler, et al.
Cell Transplantation|February 7, 2016
Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease FibroblastsKyle D Fink, Peter Deng, Josh Gutierrez, et al.
Pageof 13